Published in Nutr Cancer on January 01, 2011
Collateral sensitivity as a strategy against cancer multidrug resistance. Drug Resist Updat (2012) 1.53
Anti-Cancer Phytometabolites Targeting Cancer Stem Cells. Curr Genomics (2017) 0.75
Established Human Cell Lines as Models to Study Anti-leukemic Effects of Flavonoids. Curr Genomics (2017) 0.75
HPLC determination of isoflavone levels in osage orange from the Midwest and southern United States. J Agric Food Chem (2013) 0.75
miR-133b down-regulates ABCC1 and enhances the sensitivity of CRC to anti-tumor drugs. Oncotarget (2017) 0.75
Synthesis and in vitro biological evaluation of thiosulfinate derivatives for the treatment of human multidrug-resistant breast cancer. Acta Pharmacol Sin (2017) 0.75
An overview on biological mechanisms of PPARs. Pharmacol Res (2005) 2.43
Presence of Hoechst low side populations in multiple myeloma. Leuk Lymphoma (2008) 1.51
Increased sensitivity of desensitized TRPV1 by PMA occurs through PKCepsilon-mediated phosphorylation at S800. Pain (2006) 1.41
Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol (2004) 1.40
Fluticasone uptake across Calu-3 cells is mediated by salmeterol when deposited as a combination powder inhaler. Respirology (2013) 1.38
Activation of protein kinase C reverses capsaicin-induced calcium-dependent desensitization of TRPV1 ion channels. Cell Calcium (2004) 1.33
Anti-diabetic action of Punica granatum flower extract: activation of PPAR-gamma and identification of an active component. Toxicol Appl Pharmacol (2005) 1.27
Glioma microvesicles carry selectively packaged coding and non-coding RNAs which alter gene expression in recipient cells. RNA Biol (2013) 1.26
Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger. Thromb Res (2003) 1.25
Punica granatum flower extract, a potent alpha-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats. J Ethnopharmacol (2005) 1.23
Microparticle-associated nucleic acids mediate trait dominance in cancer. FASEB J (2011) 1.13
Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol (2005) 1.11
Gingerols: a novel class of vanilloid receptor (VR1) agonists. Br J Pharmacol (2002) 1.11
A systematic review on the Rosa canina effect and efficacy profiles. Phytother Res (2008) 1.07
Actin disruption inhibits endosomal traffic of P-glycoprotein-EGFP and resistance to daunorubicin accumulation. Am J Physiol Cell Physiol (2006) 1.06
Pomegranate flower: a unique traditional antidiabetic medicine with dual PPAR-alpha/-gamma activator properties. Diabetes Obes Metab (2008) 1.06
Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits. Mol Cancer (2012) 1.05
Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy? Drug Metab Dispos (2014) 1.05
Culturable endophytes of medicinal plants and the genetic basis for their bioactivity. Microb Ecol (2012) 1.01
Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: modulation of cardiac PPAR-alpha-mediated transcription of fatty acid metabolic genes. Toxicol Appl Pharmacol (2005) 1.01
Modulation of ionotropic GABA receptors by natural products of plant origin. Adv Pharmacol (2006) 1.00
Protective effects of ethanolic extract of Zingiber officinale rhizome on the development of metabolic syndrome in high-fat diet-fed rats. Basic Clin Pharmacol Toxicol (2009) 0.99
Breast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cells. PLoS One (2013) 0.99
Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR-alpha. Toxicol Appl Pharmacol (2005) 0.97
Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome. Basic Clin Pharmacol Toxicol (2005) 0.97
Bilobalide, a sesquiterpene trilactone from Ginkgo biloba, is an antagonist at recombinant alpha1beta2gamma2L GABA(A) receptors. Eur J Pharmacol (2003) 0.96
Anti-hyperlipidemic and hypoglycemic effects of Gynostemma pentaphyllum in the Zucker fatty rat. J Pharm Pharm Sci (2006) 0.96
A comprehensive review on the stinging nettle effect and efficacy profiles. Part II: urticae radix. Phytomedicine (2007) 0.96
The pathophysiological function of peroxisome proliferator-activated receptor-gamma in lung-related diseases. Respir Res (2005) 0.96
Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids. Br J Pharmacol (2005) 0.95
Dynamic and intracellular trafficking of P-glycoprotein-EGFP fusion protein: Implications in multidrug resistance in cancer. Int J Cancer (2004) 0.95
Phytopreventative anti-hyperlipidemic effects of gynostemma pentaphyllum in rats. J Pharm Pharm Sci (2005) 0.94
Time- and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model. Drug Dev Ind Pharm (2010) 0.93
ThermoTRP channels in nociceptors: taking a lead from capsaicin receptor TRPV1. Curr Neuropharmacol (2008) 0.93
Gypenosides derived from Gynostemma pentaphyllum suppress NO synthesis in murine macrophages by inhibiting iNOS enzymatic activity and attenuating NF-kappaB-mediated iNOS protein expression. Nitric Oxide (2003) 0.93
Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology. Br J Pharmacol (2012) 0.92
Preventive and Protective Properties of Zingiber officinale (Ginger) in Diabetes Mellitus, Diabetic Complications, and Associated Lipid and Other Metabolic Disorders: A Brief Review. Evid Based Complement Alternat Med (2012) 0.92
Herbal medicines and nutraceuticals for diabetic vascular complications: mechanisms of action and bioactive phytochemicals. Curr Pharm Des (2010) 0.90
Regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase expression by Zingiber officinale in the liver of high-fat diet-fed rats. Basic Clin Pharmacol Toxicol (2009) 0.90
Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia. Pharm Res (2012) 0.89
Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor. Blood (2005) 0.88
Gypenoside XLIX isolated from Gynostemma pentaphyllum inhibits nuclear factor-kappaB activation via a PPAR-alpha-dependent pathway. J Biomed Sci (2006) 0.88
Gingerols of Zingiber officinale enhance glucose uptake by increasing cell surface GLUT4 in cultured L6 myotubes. Planta Med (2012) 0.87
Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant alpha1beta2gamma2L GABAA receptors. Eur J Pharmacol (2004) 0.87
Pomegranate flower extract diminishes cardiac fibrosis in Zucker diabetic fatty rats: modulation of cardiac endothelin-1 and nuclear factor-kappaB pathways. J Cardiovasc Pharmacol (2005) 0.87
Protein kinase C modulation of thermo-sensitive transient receptor potential channels: Implications for pain signaling. J Nat Sci Biol Med (2011) 0.86
Attenuation of Proinflammatory Responses by S-[6]-Gingerol via Inhibition of ROS/NF-Kappa B/COX2 Activation in HuH7 Cells. Evid Based Complement Alternat Med (2013) 0.86
Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kappa B activation. J Ethnopharmacol (2005) 0.86
Salacia oblonga improves cardiac fibrosis and inhibits postprandial hyperglycemia in obese Zucker rats. Life Sci (2004) 0.86
Attenuation of liver pro-inflammatory responses by Zingiber officinale via inhibition of NF-kappa B activation in high-fat diet-fed rats. Basic Clin Pharmacol Toxicol (2011) 0.86
Guanidino acids act as rho1 GABA(C) receptor antagonists. Neurochem Res (2009) 0.86
Ginkgolide B and bilobalide block the pore of the 5-HT₃receptor at a location that overlaps the picrotoxin binding site. Neuropharmacology (2010) 0.86
Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines. J Ethnopharmacol (2012) 0.86
A comprehensive review on nettle effect and efficacy profiles, Part I: herba urticae. Phytomedicine (2007) 0.85
Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management. Expert Opin Drug Deliv (2011) 0.85
Hyperforin and its analogues inhibit CYP3A4 enzyme activity. Phytochemistry (2006) 0.85
Characterization of PXR mediated P-glycoprotein regulation in intestinal LS174T cells. Pharmacol Res (2010) 0.84
Gingerol metabolite and a synthetic analogue Capsarol inhibit macrophage NF-kappaB-mediated iNOS gene expression and enzyme activity. Planta Med (2006) 0.84
Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways. Pharmacol Res (2013) 0.84
Gypenoside XLIX, a naturally occurring gynosaponin, PPAR-alpha dependently inhibits LPS-induced tissue factor expression and activity in human THP-1 monocytic cells. Toxicol Appl Pharmacol (2006) 0.84
Topical 'Sydney' propolis protects against UV-radiation-induced inflammation, lipid peroxidation and immune suppression in mouse skin. Int Arch Allergy Immunol (2009) 0.84
Cell-derived microparticles: new targets in the therapeutic management of disease. J Pharm Pharm Sci (2013) 0.84
Epithelial profiling of antibiotic controlled release respiratory formulations. Pharm Res (2011) 0.83
Factors influencing the abundance of the side population in a human myeloma cell line. Bone Marrow Res (2011) 0.83
Mutations of the 2' proline in the M2 domain of the human GABAC rho1 subunit alter agonist responses. Neuropharmacology (2004) 0.83
Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects. Br J Clin Pharmacol (2010) 0.83
Potent cytotoxic effects of Calomeria amaranthoides on ovarian cancers. J Exp Clin Cancer Res (2011) 0.82
Effectiveness of Harpagophytum extracts and clinical efficacy. Phytother Res (2004) 0.82
Methodologies for investigating natural medicines for the treatment of nonalcoholic fatty liver disease (NAFLD). Curr Pharm Biotechnol (2012) 0.82
Cellular communication via microparticles: role in transfer of multidrug resistance in cancer. Future Oncol (2014) 0.82
Lycium barbarum (Goji Berry) extracts and its taurine component inhibit PPAR-γ-dependent gene transcription in human retinal pigment epithelial cells: Possible implications for diabetic retinopathy treatment. Biochem Pharmacol (2011) 0.82
A novel LXR-alpha activator identified from the natural product Gynostemma pentaphyllum. Biochem Pharmacol (2005) 0.81
Bromelain improves decrease in defecation in postoperative rats: modulation of colonic gene expression of inducible nitric oxide synthase. Life Sci (2005) 0.81
Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance. Eur J Pharmacol (2013) 0.81
Fabrication of Curcumin Micellar Nanoparticles with Enhanced Anti-Cancer Activity. J Biomed Nanotechnol (2015) 0.80
Ciprofloxacin is actively transported across bronchial lung epithelial cells using a Calu-3 air interface cell model. Antimicrob Agents Chemother (2013) 0.80
Deposition, diffusion and transport mechanism of dry powder microparticulate salbutamol, at the respiratory epithelia. Mol Pharm (2012) 0.80
Prenylated cinnamate and stilbenes from Kangaroo Island propolis and their antioxidant activity. Phytochemistry (2012) 0.80
The effect of vitamin D3 and ketoconazole combination on VDR-mediated P-gp expression and function in human colon adenocarcinoma cells: implications in drug disposition and resistance. Basic Clin Pharmacol Toxicol (2011) 0.80
The small GTPases Rab5 and RalA regulate intracellular traffic of P-glycoprotein. Biochim Biophys Acta (2007) 0.80
Healing the diabetic heart: modulation of cardiometabolic syndrome through peroxisome proliferator activated receptors (PPARs). Curr Mol Pharmacol (2012) 0.80
Gypenoside XLIX, a naturally occurring PPAR-alpha activator, inhibits cytokine-induced vascular cell adhesion molecule-1 expression and activity in human endothelial cells. Eur J Pharmacol (2007) 0.80
Monoepoxy octadecadienoates and monoepoxy octadecatrienoates 1: NMR spectral characterization. Chem Phys Lipids (2008) 0.80